Certified Drug Free – Testing Menu
February 9, 2021 1,2,3,4,5,6
The BSCG Certified Drug Free® industry leading testing menu is used to screen dietary supplements, natural products, cosmetics, medical devices, CBD products or their ingredients for more than 491+ drugs. This includes 287+ drugs on the World Anti-Doping Agency (WADA) Prohibited List and 204+ illicit, prescription and over-the-counter drugs not banned in sport. The BSCG Certified Drug Free® testing menu offers the most comprehensive protection available among providers of third-party certification for banned substances covering more than 94% of the positive drug tests reported by WADA labs since 2007.
The WADA Prohibited List serves as a model for professional sport, military, and first responder drug testing programs worldwide, which ban many of the compounds on the WADA Prohibited List. As a result, the BSCG Certified Drug Free® certification program offers security to athletes and professionals across the spectrum of WADA, NFL, MLB, NHL, NBA, WNBA, PGA, LPGA, MLS, CFL, ATP, WTA, FIFA, FINA, AFL, NRL, NASCAR, UFC, CrossFit, NCAA, military, first responder, and other drug-testing programs.
BSCG Certified Drug Free® is proud to be the only certification program to add screening for drugs not banned in sport. Drugs like PDE-5 inhibitors (viagra), muscle relaxants, pain-killers, opioids, antidepressants, benzodiazepines, and more are covered adding significant health protection for athletes and general consumers. Statistics show that 74% of the drug contamination found by the FDA in tainted supplements comes from drugs not banned in sport.
BSCG is also the only certification program to offer an optional expanded testing menu focused on protection of animal supplements for equines and canines, which includes screening for drugs banned by the “Association of Racing Commissioners International, Inc. Uniform Classification Guidelines for Foreign Substances” or on the “Equine Prohibited Substances List” as defined by the Federation Equine International (FEI).
The BSCG Certified Drug Free® testing menu below lists compounds banned in sport first followed by the illicit, prescription and over-the-counter drugs not banned in sport. Compounds banned in sport are sorted by the categories in the WADA Prohibited List then alphabetically. Compounds not banned in sport are arranged alphabetically and include the general pharmaceutical category for the drug. Notes and Reporting Level details are provided at the bottom.
Compounds Banned in Sport
| Compound | WADA Category |
| 4-Hydroxypropranolol | P1 – BetaBlockers |
| Acebutolol | P1 – BetaBlockers |
| Atenolol | P1 – BetaBlockers |
| Bisoprolol | P1 – BetaBlockers |
| Carteolol | P1 – BetaBlockers |
| Desmethylmetoprolol | P1 – BetaBlockers |
| Hydroxymetoprolol | P1 – BetaBlockers |
| Labetalol | P1 – BetaBlockers |
| Metoprolol | P1 – BetaBlockers |
| Nadolol | P1 – BetaBlockers |
| O-Desmethylmetoprolol | P1 – BetaBlockers |
| Oxprenolol | P1 – BetaBlockers |
| Propranolol | P1 – BetaBlockers |
| Sotalol | P1 – BetaBlockers |
| Timolol | P1 – BetaBlockers |
| 16β-hydroxystanozolol | S1 – Anabolic Agents |
| 17-hydroxyprogesterone (17-α-hydroxyprogesterone) | S1 – Anabolic Agents |
| 19-norandrostenediol (estr-4-ene-3,17-diol) | S1 – Anabolic Agents |
| 19-norandrostenedione (estr-4-ene-3,17-dione) | S1 – Anabolic Agents |
| 1-androstenedione (5α-androst-1-ene-3,17-dione, 1-AD) | S1 – Anabolic Agents |
| 1-testosterone (17β-hydroxy-5α-androst-1-en-3-one) | S1 – Anabolic Agents |
| 3-hydroxy-stanozolol | S1 – Anabolic Agents |
| 4-androstenediol (androst-4-ene-3β,17β-diol) | S1 – Anabolic Agents |
| 4-hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3-one) | S1 – Anabolic Agents |
| 5-androstenedione (androst-5-ene-3,17-dione; 5-androsten-3, 17-dione) | S1 – Anabolic Agents |
| 5α-androstane-3α,17β-diol (Androstanediol, Hombreol) | S1 – Anabolic Agents |
| 5α-androstane-3β,17α-diol | S1 – Anabolic Agents |
| 5α-androstane-3β,17β-diol | S1 – Anabolic Agents |
| 5α-Estran-3β,17α-diol (Tetrahyrdonandrolone) | S1 – Anabolic Agents |
| 6-Bromoandrostenedione | S1 – Anabolic Agents |
| 6α-hydroxyandrostenedione | S1 – Anabolic Agents |
| 6β-hydroxymethandienone | S1 – Anabolic Agents |
| 6β-hydroxyturinabol | S1 – Anabolic Agents |
| Andarine | S1 – Anabolic Agents |
| Androstanolone (5a-dihydrotestosterone; 17β-hydroxy-5α-androstan-3-one) | S1 – Anabolic Agents |
| Androsterone (3α-hydroxy-5α-androstan-17-one) | S1 – Anabolic Agents |
| Bolasterone | S1 – Anabolic Agents |
| Boldenone (17beta-hydroxyandrost-1,4-diene-3-one) | S1 – Anabolic Agents |
| Boldione (androsta-1,4-diene-3,17-dione; androstadienedione) | S1 – Anabolic Agents |
| Calusterone | S1 – Anabolic Agents |
| Clenbuterol | S1 – Anabolic Agents |
| Clostebol | S1 – Anabolic Agents |
| Danazol ([1,2]oxazolo[4′,5′:2,3]pregna-4-en-20-yn-17α-ol; or 17α-ethynyl-17β-hydroxyandrost-4-eno[2,3-d]isoxazole) | S1 – Anabolic Agents |
| Dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one; Oral-turinabol) | S1 – Anabolic Agents |
| Drostanolone | S1 – Anabolic Agents |
| Epiboldenone | S1 – Anabolic Agents |
| Epimethandienone | S1 – Anabolic Agents |
| Epioxandrolone | S1 – Anabolic Agents |
| Epitestosterone | S1 – Anabolic Agents |
| Epitrenbolone | S1 – Anabolic Agents |
| Ethylestrenol (19-norpregna-4-en-17α-ol; or 19-nor-17α-pregn-4-en-17-ol) | S1 – Anabolic Agents |
| Etiocholanolone | S1 – Anabolic Agents |
| Fluoxymesterone | S1 – Anabolic Agents |
| Formebolone | S1 – Anabolic Agents |
| Gestrinone | S1 – Anabolic Agents |
| Hydroxyandrosterone,Hydroxyetiocholanolone | S1 – Anabolic Agents |
| LGD-4033 (Ligandrol) | S1 – Anabolic Agents |
| Mestanolone | S1 – Anabolic Agents |
| Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one; methandrostenolone) | S1 – Anabolic Agents |
| Metenolone | S1 – Anabolic Agents |
| Methandriol | S1 – Anabolic Agents |
| Methasterone (17β-hydroxy-2α,17α-dimethyl-5α- androstan-3-one; or 2α, 17α-dimethyl-5α-androstane-3-one-17β-ol) |
S1 – Anabolic Agents |
| Methyl-1-testosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one) | S1 – Anabolic Agents |
| Methyldienolone (17β-hydroxy-17α-methylestra-4,9-dien-3-one) | S1 – Anabolic Agents |
| Methylnortestosterone (17β-hydroxy-17α-methylestr-4-en-3-one, Normethandrolone, 17α-methyl-19-nortestosterone) | S1 – Anabolic Agents |
| Methyltestosterone | S1 – Anabolic Agents |
| Metribolone (Methyltrienolone, 17β-hydroxy-17α-methylestra-4,9,11-trien-3-one) | S1 – Anabolic Agents |
| Mibolerone | S1 – Anabolic Agents |
| Nandrolone (19-nortestosterone) | S1 – Anabolic Agents |
| Norbolethone | S1 – Anabolic Agents |
| Norclostebol | S1 – Anabolic Agents |
| Norethandrolone | S1 – Anabolic Agents |
| Ostarine | S1 – Anabolic Agents |
| Oxabolone | S1 – Anabolic Agents |
| Oxandrolone | S1 – Anabolic Agents |
| Oxymesterone | S1 – Anabolic Agents |
| Oxymetholone | S1 – Anabolic Agents |
| Prasterone (dehydroepiandrosterone; DHEA; 3β-hydroxyandrost-5-en-17-one) | S1 – Anabolic Agents |
| Prostanozol (17β-[(tetrahydropyran-2-yl)oxy]-1’Hpyrazolo[3,4:2,3]-5α-androstane; or 17β-hydroxy-5α-androstano[3,2-c] pyrazole) | S1 – Anabolic Agents |
| Quinbolone | S1 – Anabolic Agents |
| Ractopamine | S1 – Anabolic Agents |
| Stanozolol | S1 – Anabolic Agents |
| Stenbolone | S1 – Anabolic Agents |
| Testosterone | S1 – Anabolic Agents |
| Tetrahydrogestrinone (17-hydroxy-18a-homo-19-nor-17α- pregna-4,9,11-trien-3-one; or 18a-homo-pregna-4,9,11-trien-17β-ol-3-one; or THG) |
S1 – Anabolic Agents |
| Tibolone | S1 – Anabolic Agents |
| Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one) | S1 – Anabolic Agents |
| Turinabol (Clostebol acetate) | S1 – Anabolic Agents |
| Zeranol | S1 – Anabolic Agents |
| Zilpaterol | S1 – Anabolic Agents |
| Cobalt | S2 – Peptide Hormones, Growth Factors, Related Substances, and Mimetics |
| Examorelin (Hexarelin) | S2 – Peptide Hormones, Growth Factors, Related Substances, and Mimetics |
| Ibutamoren (MK-677) | S2 – Peptide Hormones, Growth Factors, Related Substances, and Mimetics |
| Ipamorelin | S2 – Peptide Hormones, Growth Factors, Related Substances, and Mimetics |
| Thymosin β4 (N-acetylated_LK) | S2 – Peptide Hormones, Growth Factors, Related Substances, and Mimetics |
| Thymosin-β4-(N-acetylated_LKKTETQ) | s2 – Peptide Hormones, Growth Factors, Related Substances, and Mimetics |
| 3-methyl-colterolol | S3 – Beta-2 Agonists |
| Albuterol | S3 – Beta-2 Agonists |
| Bambuterol | S3 – Beta-2 Agonists |
| Bitolterol | S3 – Beta-2 Agonists |
| Brombuterol | S3 – Beta-2 Agonists |
| Clenpenterol | S3 – Beta-2 Agonists |
| Fenoterol | S3 – Beta-2 Agonists |
| Formoterol | S3 – Beta-2 Agonists |
| Higenamine (norcoclaurine) | S3 – Beta-2 Agonists |
| Isoxsuprine | S3 – Beta-2 Agonists |
| Metaproterenol | S3 – Beta-2 Agonists |
| Pirbuterol | S3 – Beta-2 Agonists |
| Ritodrine | S3 – Beta-2 Agonists |
| Salmeterol | S3 – Beta-2 Agonists |
| Terbutaline | S3 – Beta-2 Agonists |
| 4-androstene-3,6,17 trione (6-OXO; Androstenetrione) | S4 – Hormone & Metabolic Modulators |
| AICAR | S4 – Hormone & Metabolic Modulators |
| Anastrozole | S4 – Hormone & Metabolic Modulators |
| Androsta-1,4,6-triene-3,17-dione (androstatrienedione, ATD) | S4 – Hormone & Metabolic Modulators |
| Androsta-3,5-diene-7,17-dione (arimistane) | S4 – Hormone & Metabolic Modulators |
| Clomiphene | S4 – Hormone & Metabolic Modulators |
| Formestane (4-hydroxyandrostenedione) | S4 – Hormone & Metabolic Modulators |
| GW 1516 (Cardarine) | S4 – Hormone & Metabolic Modulators |
| Letrozole | S4 – Hormone & Metabolic Modulators |
| Meldonium | S4 – Hormone & Metabolic Modulators |
| Raloxifene | S4 – Hormone & Metabolic Modulators |
| Tamoxifen | S4 – Hormone & Metabolic Modulators |
| Trimetazidine | S4 – Hormone & Metabolic Modulators |
| Acetazolamide | S5 – Diuretics & Masking Agents |
| Amiloride | S5 – Diuretics & Masking Agents |
| Bendroflumethiazide | S5 – Diuretics & Masking Agents |
| Benzthiazide | S5 – Diuretics & Masking Agents |
| Bumetanide | S5 – Diuretics & Masking Agents |
| Canrenone | S5 – Diuretics & Masking Agents |
| Chlorothiazide (thiazide) | S5 – Diuretics & Masking Agents |
| Chlortalidone | S5 – Diuretics & Masking Agents |
| Clopamide | S5 – Diuretics & Masking Agents |
| Cyclothiazide | S5 – Diuretics & Masking Agents |
| Etacrynic acid | S5 – Diuretics & Masking Agents |
| Flumethiazide | S5 – Diuretics & Masking Agents |
| Furosemide | S5 – Diuretics & Masking Agents |
| Hydrochlorothiazide | S5 – Diuretics & Masking Agents |
| Hydroflumethiazide | S5 – Diuretics & Masking Agents |
| Indapamide | S5 – Diuretics & Masking Agents |
| Methyclothiazide | S5 – Diuretics & Masking Agents |
| Metolazone | S5 – Diuretics & Masking Agents |
| Piretanide | S5 – Diuretics & Masking Agents |
| Polythiazide | S5 – Diuretics & Masking Agents |
| Probenecid | S5 – Diuretics & Masking Agents |
| Quinethazone | S5 – Diuretics & Masking Agents |
| Spironolactone | S5 – Diuretics & Masking Agents |
| Torasemide | S5 – Diuretics & Masking Agents |
| Triamterene | S5 – Diuretics & Masking Agents |
| Trichlormethiazide | S5 – Diuretics & Masking Agents |
| 2-Amino-6-Methylheptane (DMHA, Octodrine, 1,5-Dimethylhexlyamine, 6-methyl-2-heptylamine)) | S6 – Stimulants |
| 3,4-methylenedioxypyprovalerone (MDPV) | S6 – Stimulants |
| 3-methoxytyramine | S6 – Stimulants |
| 4-Bromo-2,5-dimethoxyamphetamine (Dimethoxybromoamphetamine, DOB, brolamfetamine, bromo-DMA) | S6 – Stimulants |
| 4-Bromo-2,5-Dimethoxyphenethylamine | S6 – Stimulants |
| 4-fluoromethcathinone (Flephedrone) | S6 – Stimulants |
| 4-methylhexan-2-amine (DMAA, methylhexaneamine; 1,3-dimethylpentylamine; dimethylamylamine) | S6 – Stimulants |
| 4-Methylpentan-2-amine (1,3-dimethylbutylamine, DMBA, AMP Citrate) | S6 – Stimulants |
| Amfepramone (Diethylproprion) | S6 – Stimulants |
| Aminorex | S6 – Stimulants |
| Amphetamine | S6 – Stimulants |
| Benfluorex | S6 – Stimulants |
| Benzoylecgonine | S6 – Stimulants |
| Benzphetamine | S6 – Stimulants |
| Benzylpiperazine | S6 – Stimulants |
| Cathine** (Norpseudoephedrine) | S6 – Stimulants |
| Cathinone | S6 – Stimulants |
| Clobenzorex | S6 – Stimulants |
| Cocaine | S6 – Stimulants |
| d-Amphetamine (Dexamfetamine, Dextroamphetamine) | S6 – Stimulants |
| Desmethylselegiline (nordeprenyl) | S6 – Stimulants |
| Ephedrine*** | S6 – Stimulants |
| Etamivan | S6 – Stimulants |
| Ethylamphetamine | S6 – Stimulants |
| Ethylphenidate | S6 – Stimulants |
| Etilefrine | S6 – Stimulants |
| Famprofazone | S6 – Stimulants |
| Fenfluramine | S6 – Stimulants |
| Fenproporex | S6 – Stimulants |
| Fonturacetam (4-phenylpiracetam; carphedon) | S6 – Stimulants |
| Heptaminol (6-Amino-2-methyl-heptanol) | S6 – Stimulants |
| Isometheptene | S6 – Stimulants |
| Levmetamfetamine | S6 – Stimulants |
| Mazindol | S6 – Stimulants |
| Mefenorex | S6 – Stimulants |
| Mephedrone (4-methylmethcathinone) | S6 – Stimulants |
| Mephentermine | S6 – Stimulants |
| Mescaline (3,4,5-trimethoxyphenethylamine) | S6 – Stimulants |
| Metaraminol | S6 – Stimulants |
| Methamphetamine(d-) | S6 – Stimulants |
| Methylbenzodioxolylbutanamine (MBDB) | S6 – Stimulants |
| Methylenedioxyethylamphetamine (MDEA) | S6 – Stimulants |
| Methylenedioxymethamphetamine (MDMA) | S6 – Stimulants |
| Methylephedrine*** | S6 – Stimulants |
| Methylone (3,4-Methylenedioxy-N-methcathinone) | S6 – Stimulants |
| Methylphenidate | S6 – Stimulants |
| Modafinil | S6 – Stimulants |
| Modafinil Acid | S6 – Stimulants |
| N,N-dimethylphenethylamine | S6 – Stimulants |
| Nicotine | S6 – Stimulants |
| Nikethamide | S6 – Stimulants |
| N-methylphenethylamine | S6 – Stimulants |
| Noopept (Omberacetam) | S6 – Stimulants |
| Norfenfluramine (3-trifluoromethylamphetamine) | S6 – Stimulants |
| N-α-diethyl-phenethylamine (N,a-DEPEA; N-alpha-diethylphenethylamine, N-ethyl-1-phenyl-2-butanamine) | S6 – Stimulants |
| N-β-diethyl-phenethylamine | S6 – Stimulants |
| Octopamine | S6 – Stimulants |
| Oxilofrine (Methylsynephrine) | S6 – Stimulants |
| para-Methoxyamphetamine (PMA, Methoxyamfetamine) | S6 – Stimulants |
| para-Methoxymethamphetamine (PMMA) | S6 – Stimulants |
| p-Chloroamphetamine | S6 – Stimulants |
| Pemoline | S6 – Stimulants |
| Pentetrazol (Pentylenetetrazole) | S6 – Stimulants |
| Phendimetrazine | S6 – Stimulants |
| Phenethylamine and its derivatives (PEA) | S6 – Stimulants |
| Phenmetrazine | S6 – Stimulants |
| Phentermine | S6 – Stimulants |
| Phenylpropanolamine (PPA, norephedrine) | S6 – Stimulants |
| Pholedrine (4-hydroxy-N-methylamphetamine (4-HMA)) | S6 – Stimulants |
| Propylhexedrine | S6 – Stimulants |
| Pseudoephedrine***** | S6 – Stimulants |
| Ritalinic Acid | S6 – Stimulants |
| Selegiline (L-deprenyl) | S6 – Stimulants |
| Sibutramine | S6 – Stimulants |
| Strychnine | S6 – Stimulants |
| Synephrine | S6 – Stimulants |
| Tenamfetamine (methylenedioxyamphetamine; (MDA) | S6 – Stimulants |
| Tuaminoheptane | S6 – Stimulants |
| α-Pyrrolidinovalerophenone | S6 – Stimulants |
| Alfentanil | S7 – Narcotics |
| Buprenorphine | S7 – Narcotics |
| Carfentanil | S7 – Narcotics |
| Codeine | S7 – Narcotics |
| Desomorphine | S7 – Narcotics |
| Despropionylfentanyl | S7 – Narcotics |
| Diamorphine (heroin) | S7 – Narcotics |
| Fentanyl | S7 – Narcotics |
| GHB (γ-Hydroxybutyric acid; 4-hydroxybutanoic acid) | S7 – Narcotics |
| Hydrocodone | S7 – Narcotics |
| Hydromorphone | S7 – Narcotics |
| LSD | S7 – Narcotics |
| Methadone | S7 – Narcotics |
| Morphine | S7 – Narcotics |
| Oxycodone | S7 – Narcotics |
| Oxymorphone | S7 – Narcotics |
| Pentazocine | S7 – Narcotics |
| Pethidine (Meperidine) | S7 – Narcotics |
| Phencyclidine (PCP) | S7 – Narcotics |
| Remifentanyl | S7 – Narcotics |
| Sufentanil | S7 – Narcotics |
| Tramadol | S7 – Narcotics |
| 11-Hydroxy-Delta-9-THC | S8 – Cannabinoids |
| 11-Nor9-Carboxy-Δ9-Tetrahydrocannabinol | S8 – Cannabinoids |
| Spice_Cannabinoid_(JWH-018) | S8 – Cannabinoids |
| Spice_Cannabinoid_(JWH-073) | S8 – Cannabinoids |
| Spice_Cannabinoid_(JWH-073_Metabolite) | S8 – Cannabinoids |
| Spice_Cannabinoid_(JWH-250 4-Hydrox pentyl metabolite) | S8 – Cannabinoids |
| Spice_Cannabinoid_(JWH-250 5-Hydrox pentyl metabolite) | S8 – Cannabinoids |
| Spice_Cannabinoid_(JWH-250) | S8 – Cannabinoids |
| THC (Delta 9-tetrahyrdocannabinol) | S8 – Cannabinoids |
| 6-α-fluprednisolone | S9 – Glucocorticosteroids |
| Beclomethasone | S9 – Glucocorticosteroids |
| Betamethasone | S9 – Glucocorticosteroids |
| Budesonide | S9 – Glucocorticosteroids |
| Cortiisone | S9 – Glucocorticosteroids |
| Deflazacort | S9 – Glucocorticosteroids |
| Deoxycorticosterone | S9 – Glucocorticosteroids |
| Desoximetasone | S9 – Glucocorticosteroids |
| Dexamethasone | S9 – Glucocorticosteroids |
| Fludrocortisone | S9 – Glucocorticosteroids |
| Flumethasone | S9 – Glucocorticosteroids |
| Fluocinonide | S9 – Glucocorticosteroids |
| Fluorometholone | S9 – Glucocorticosteroids |
| Flurandrenolide | S9 – Glucocorticosteroids |
| Flurandrenolide | S9 – Glucocorticosteroids |
| Fluticasone Propionate | S9 – Glucocorticosteroids |
| Halcinonide | S9 – Glucocorticosteroids |
| Hydrocortisone | S9 – Glucocorticosteroids |
| Isoflupredone | S9 – Glucocorticosteroids |
| Meprednisone | S9 – Glucocorticosteroids |
| Methylprednisolone | S9 – Glucocorticosteroids |
| Mometasone | S9 – Glucocorticosteroids |
| Paramethasone | S9 – Glucocorticosteroids |
| Prednisolone | S9 – Glucocorticosteroids |
| Prednisone | S9 – Glucocorticosteroids |
| Triamcinolone | S9 – Glucocorticosteroids |
| Triamcinolone Acetonide | S9 – Glucocorticosteroids |
Compounds Not Banned in Sport
| Compound | General Category |
| 2-(1-Hydroxyethyl)promazine sulfoxide | Antipsychotic |
| 2-(1-Hydroxypropyl)promazine sulfoxide | Antipsychotic |
| 4-Aminoantipyrine | Analgesic/antipyretic |
| 7-Hydroxychlorpromazine | Antipsychotic |
| 7-hydroxymitragynine | Analgesic/antipyretic |
| Acemetacin | NSAID |
| Acepromazine | Sedative |
| Acetaminophen | Analgesic |
| Acetanilide | Analgesic/antipyretic |
| Acetildenafil | PDE-5 Inhibitor |
| Acetophenazine | Antipsychotic |
| Acetophenetidin (Phenacetin) | Antipsychotic |
| Acetylcysteine | Mucolytic |
| Acetylsalicylic acid | Analgesic |
| AH-7921 | Opiod |
| Aldosterone | Opiod |
| Alprostatdil (Prostaglandin E1) | Prostaglandin |
| Altrenogest | Progestin |
| Aminocaproic acid | Progestin |
| Aminophylline | Bronchodilator |
| Aminopyrine | Analgesic/antipyretic |
| Amitriptyline | Antidepressant |
| Amoxapine | Antidepressant |
| Anileridine | Analgesic/antipyretic |
| Antipyrine | Analgesic/antipyretic |
| Apomorphine | Opiod |
| Atropine | Anticholinergic |
| Avanafil | PDE-5 Inhibitor |
| Azaperone | Anticholinergic |
| Benoxaprofen | NSAID |
| Benzocaine | Local Anesthetic |
| Bufexamac | NSAID |
| Bufotenine | Tryptamine |
| Bupivacaine | Local Anesthetic |
| Buspirone | Anxiolytic |
| Butorphanol | Opiod |
| Camphor | Opiod |
| Capsaicin | Opiod |
| Carbazochrome | Haemostatic |
| Carboxydetomidine | Haemostatic |
| Carisoprodol | Muscle relaxant |
| Carprofen | NSAID |
| Celecoxib | NSAID |
| Cetirizine | Antihistamine |
| Chlorpheniramine | Antihistamine |
| Chlorpromazine | Sedative |
| Clodronic Acid | Antihistamine |
| Clonidine | Stimulant |
| Cotinine | Stimulant |
| Cyclobenzaprine | Muscle relaxant |
| Dantrolene | Muscle relaxant |
| Dehydronorketamine | Sedative |
| Deracoxib | NSAID |
| Dermorphin | Opiod |
| Desipramine | Antidepressant |
| Desvenlafaxine (O-desmethylvenlafaxine) | Antidepressant |
| Detomidine | Sedative |
| Dextromethorphan | Antitussive |
| Dextrorphan | Antitussive |
| Dezocine | Opiod |
| Diazepam | Benzodiazepines |
| Dichloroacetic acid (dichloroacetate, dichloroethanoic acid) | Metabolic Modulator |
| Diclofenac | NSAID |
| Diflunisal | NSAID |
| Dihydromorphine | Opiod |
| Diphenhydramine | Antihistamine |
| Dipyrone | Antihistamine |
| Doxepin | Antidepressant |
| Droperidol | Antipsychotic |
| Dyphylline | Bronchodilator |
| Echinopsine | Stimulant |
| Eltenac | NSAID |
| Estazolam | Benzodiazepines |
| Etamiphylline | Bronchodilator |
| Etamsylate | Haemostatic agent/antihemmorhagic |
| Ethylmorphine | Opiod |
| Etodolac | NSAID |
| Etorphine | Opiod |
| Fenoprofen | NSAID |
| Fenspiride | Antitussive |
| Firoxocib | NSAID |
| Flucinolone Acetonide | NSAID |
| Flufenamic acid | NSAID |
| Flunitrazepam | NSAID |
| Flunixin | NSAID |
| Fluoxetine | Weight Loss |
| Fluphenazine | Antipsychotic |
| Fluphenazine Sulfoxide | Antipsychotic |
| Flupirtine | Analgesic |
| Flurbiprofen | NSAID |
| Gabapentin | Anticonvulsant |
| Glaucine | Alkaloid |
| Glycopyrrolate | Anticholinergic |
| Guanabenz | Sedative |
| Hydroxyacetildenafil | PDE-5 Inhibitor |
| Hydroxycarisoprodol | Muscle relaxant |
| Hydroxyhomosildenafil | PDE-5 Inhibitor |
| Hydroxyzine | Sedative |
| Ibuprofen | Muscarinic |
| Imipramine | Antidepressant |
| Indomethacin | NSAID |
| Ipratropium | NSAID |
| Ketamine | Anaesthetic |
| Ketoprofen | NSAID |
| Ketorolac | NSAID |
| Levamisole | Anthelminthic/immunomodulatory |
| Levorphanol | Anthelminthic/immunomodulatory |
| Lidocaine | Local Anesthetic |
| Lobeline | Alkaloid |
| L-Thyroxine | Narcotic |
| Meclofenamic Acid | NSAID |
| Medetomidine | NSAID |
| Medroxyprogesterone Acetate | Progestin |
| Mefenamic Acid | NSAID |
| Meloxicam | NSAID |
| Mephenytoin | Anticonvulsant/Weight loss |
| Mepivacaine | Local Anesthetic |
| Meprobamate | Anxiolytic |
| Methaqualone | Sedative |
| Methocarbamol | Muscle relaxant |
| Methotrexate | Immunomodulator |
| Mitragynine (Kratom) | Alkaloid |
| Nabumetone | NSAID |
| Nalbuphine | Analgesic |
| Nalorphine | Analgesic |
| Naproxen | NSAID |
| N-Butylscopolamine | Anticholinergic |
| Niflumic acid | Analgesic |
| Nimesulide | NSAID |
| Nomifensine | NSAID |
| Nordiazepam | Benzodiazepines |
| Norfluoxetine | Antidepressant |
| Norketamine | Anaesthetic |
| Norlobelanine | Alkaloid |
| Normeperidine | Narcotic |
| Normorphine | Opiod |
| Nortriptyline | Antidepressant |
| Nylidrin | Sympathomimetic |
| o-desmethyl naproxen | NSAID |
| O-Desmethylpyrilamine | Antihistamine |
| O-Desmethyltramadol | Analgesic |
| Omeprazole | Proton pump inhibitor |
| Omeprazole Sulfide | Proton pump inhibitor |
| Oxaprozin | NSAID |
| Oxazepam | Benzodiazepines |
| Oxymetazoline | Decongestant |
| Oxyphenbutazone | NSAID |
| Pentobarbital | Sedative |
| Pentoxyfylline | Phosphodiesterase inhibitor |
| Perphenazine | Antipsychotic |
| Phenobarbital | Sedative |
| Phenolphthalein | Weight Loss |
| Phensuxumide | Anticonvulsant |
| Phenylbutazone | NSAID |
| Phenytoin | Anticonvulsant/Weight loss |
| p-hydroxy-phenytoin | Anticonvulsant/Weight loss |
| Piperidenafil | PDE-5 Inhibitor |
| Piroxicam | NSAID |
| Pramoxine | Antipruritic |
| Prilocaine | Local Anesthetic |
| Procaine | Local Anesthetic |
| Promazine | Sedative |
| Propantheline | Anticholinergic |
| Propiomazine | Antihistamine |
| Propionylpromazine | Sedative |
| Pyridostigmine | Anticholinesterase |
| Pyrilamine | Antihistamine |
| Quetiapine | Antihistamine |
| Reserpine | Antipsychotic |
| Rimonabant | Weight Loss |
| Rofecoxib | NSAID |
| Romifidine | Sedative |
| Salicylic acid | Analgesic |
| Scopolamine | Anticholinergic |
| Secobarbital | Sedative |
| Sertraline | Antidepressant |
| Sildenafil | PDE-5 Inhibitor |
| Sulfamethazine (Sulfadimidine) | Sulfonamide |
| Sulindac | NSAID |
| Tadalafil | PDE-5 Inhibitor |
| Tamoxifen | PDE-5 Inhibitor |
| Temazepam | Benzodiazepines |
| Tenoxicam | NSAID |
| Tepoxalin | NSAID |
| Tetracaine | Local Anesthetic |
| Thebaine | Opiod |
| Theobromine | Stimulant |
| Theophylline | Stimulant |
| Tiaprofenic Acid | NSAID |
| Tiludronic Acid | NSAID |
| Tolfenamic Acid | NSAID |
| Tolmetin | NSAID |
| Topiramate | Anticonvulsant |
| Tranexamic acid | Antifibrinolytic |
| Trazadone | Antifibrinolytic |
| Tripelennamine (PBZ) | Anaesthetic |
| Valdecoxib | NSAID |
| Vardenafil | PDE-5 Inhibitor |
| Vedaprofen | NSAID |
| Venlafaxine | Antidepressant |
| Xylazine | Sedative |
| Zolpidem | Hypnotic |
| Zomepirac | NSAID |
| Zuclopenthixol | Antipsychotic |
Notes
1 – The lists above include the majority of compounds in the BSCG Certified Drug Free® standard testing menu, but they are not exhaustive lists. BSCG regularly adds additional compounds that may not be listed here. BSCG reserves the right to make any additions, subtractions or adjustments to these lists that it deems appropriate for any reason at any time.
2 – The World Anti-Doping Agency (WADA) Category column is used to sort compounds banned in sport according to how they are organized on the WADA Prohibited List. The WADA Prohibited List is considered by many in the anti-doping community as the most robust banned substance list in human sport and is used as a guide by most other sporting groups and leagues with some groups opting to either use the WADA Prohibited List as is, or a subset of the drugs included. The compounds included are banned by most major sporting organizations including WADA, NFL, MLB, NHL, NBA, WNBA, PGA, LPGA, MLS, CFL, ATP, WTA, FIFA, FINA, AFL, NRL, NASCAR, UFC, CrossFit, NCAA, as well as military and first responder drug testing programs. Some organizations, such as NFL, MLB, and NCAA, may ban additional drugs not prohibited by WADA; those are included as relevant under the appropriate WADA category. Some compounds in the testing menu are not listed as prohibited substances but have resulted in adverse analytical findings or would be considered banned under related substance language included in certain compound categories.
3 – In addition to compounds banned in sport prescription, over-the-counter (OTC) or illicit drugs not banned in sport are also included in the testing menu. Compounds not banned in sport are organized alphabetically and include the general pharmaceutical category for reference purposes, some compounds may fit into other categories not listed.
4 – BSCG has established Method Detection Levels which represent the amount, in parts per billion (ng/g), above which a compound can be identified in a representative dietary supplement matrix. Methods have been validated to ISO 17025 standards according to the fit for purpose principle of analytical chemistry with Method Detection Levels established at a low 2-100 ng/g for most compounds with the remaining compounds in the 100-500 ng/g range. Detection levels in unique items may be lower or higher than established Method Detection Levels for certain compounds due to matrix variation or interference.
5 – Method Detection Levels were established using extractions tailored to groups of compounds based on their chemistry. Method Detection Levels are subject to the capabilities of the extraction used for the analysis. While each extraction is capable of detecting compounds for which it was not designed, the Method Detection Levels for some compounds have not been verified. Method Detection Levels for compounds with similar chemistry to those that have been validated is expected to be in the 2-500 ng/g range, but this performance is not guaranteed.
6 – An expanded testing menu may be added when certification is conducted for equine, canine, or other animal specific products or ingredients. Testing will include qualitative screening for approximately 1,300 drugs including most of the drugs banned by the “Association of Racing Commissioners International, Inc. Uniform Classification Guidelines for Foreign Substances” or on the “Equine Prohibited Substances List” as defined by the Federation Equine International (FEI). These prohibited substance lists, or a subset thereof, are used internationally for competition animals and include drugs banned by the American Graded Stakes Committee, FEI, USEF, greyhound racing, camel racing and other jurisdictions. The performance of this qualitative screen has not been fully validated.
Reporting Levels
Compounds Banned in Sport
Any amount of a compound banned in sport that is detected and meets appropriate acceptance criteria will be reported to Company and may result in a Batch not receiving Certification. Thresholds in urine, and/or plasma, defined by international testing guidelines (WADA technical documents, ARCI uniform medication guidelines, FEI…) may be considered along with potential natural presence of a compound, and/or other relevant factors, when evaluating the significance of the findings at BSCG sole discretion.
Compounds not Banned in Sport
Contamination with compounds not banned in sport at or above a reporting threshold of .0005% and/or resulting in total daily intake based on product serving suggestions of greater than 10 μg/day may result in a Batch not receiving Certification. Presence of a compound not banned in sport detected below this level will still be reported but the Batch may receive Certification. In either instance, the company must embark on a strategy to remove the presence of the compound from its product. If such a strategy is not employed the next Batch that exhibits any amount of the compound may result in that Batch not receiving Certification. If such a strategy is employed the stated reporting levels will remain in effect as the issue is addressed.
Reporting levels are always subject to BSCG review and BSCG retains the right to make any adjustments based on circumstances surrounding each case at its sole discretion.
Certified Drug Free® 
